Pregabalin vs placebo at end of treatment
Serious adverse events · patients with fibromyalgia
Pregabalin showed no clear difference in serious adverse events compared with placebo at end of treatment (moderate certainty).
1 finding from 1 review
- RR 1.03 [0.71, 1.49]4 studies · 2729 participantsModerate